SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 211 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,740,000 | -31.6% | 218,698 | -14.8% | 0.00% | -33.3% |
| Q4 2020 | $4,008,000 | +76.6% | 256,826 | +7.0% | 0.00% | +50.0% |
| Q3 2020 | $2,269,000 | +8.7% | 240,100 | +3.0% | 0.00% | 0.0% |
| Q2 2020 | $2,088,000 | +39.9% | 233,000 | -0.5% | 0.00% | 0.0% |
| Q1 2020 | $1,492,000 | -25.4% | 234,200 | -2.0% | 0.00% | 0.0% |
| Q4 2019 | $2,000,000 | +15.4% | 239,000 | +24.8% | 0.00% | 0.0% |
| Q3 2019 | $1,733,000 | +44.1% | 191,500 | +71.4% | 0.00% | +100.0% |
| Q2 2019 | $1,203,000 | -2.3% | 111,700 | -13.4% | 0.00% | -50.0% |
| Q1 2019 | $1,231,000 | -18.9% | 129,030 | -2.4% | 0.00% | 0.0% |
| Q4 2018 | $1,518,000 | -14.7% | 132,230 | +25.9% | 0.00% | 0.0% |
| Q3 2018 | $1,780,000 | +11.8% | 105,030 | -6.3% | 0.00% | 0.0% |
| Q2 2018 | $1,592,000 | -38.0% | 112,130 | -17.0% | 0.00% | -50.0% |
| Q1 2018 | $2,566,000 | +4.9% | 135,062 | -9.5% | 0.00% | +33.3% |
| Q4 2017 | $2,447,000 | +42.7% | 149,235 | +30.6% | 0.00% | 0.0% |
| Q3 2017 | $1,715,000 | +70.5% | 114,300 | 0.0% | 0.00% | +50.0% |
| Q2 2017 | $1,006,000 | +69.4% | 114,300 | 0.0% | 0.00% | +100.0% |
| Q1 2017 | $594,000 | +63.2% | 114,300 | -4.2% | 0.00% | 0.0% |
| Q4 2016 | $364,000 | -34.1% | 119,300 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $552,000 | -25.2% | 119,300 | -6.4% | 0.00% | 0.0% |
| Q2 2016 | $738,000 | -7.3% | 127,500 | -3.0% | 0.00% | 0.0% |
| Q1 2016 | $796,000 | -37.5% | 131,500 | -5.7% | 0.00% | -50.0% |
| Q4 2015 | $1,274,000 | +61.9% | 139,500 | 0.0% | 0.00% | +100.0% |
| Q3 2015 | $787,000 | -49.1% | 139,500 | 0.0% | 0.00% | -50.0% |
| Q2 2015 | $1,547,000 | -19.6% | 139,500 | 0.0% | 0.00% | -33.3% |
| Q1 2015 | $1,924,000 | 0.0% | 139,500 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $1,924,000 | +27.8% | 139,500 | 0.0% | 0.00% | +50.0% |
| Q3 2014 | $1,505,000 | -39.1% | 139,500 | -13.8% | 0.00% | -33.3% |
| Q2 2014 | $2,472,000 | +3.5% | 161,858 | +5.2% | 0.00% | 0.0% |
| Q1 2014 | $2,389,000 | +21.1% | 153,793 | +10.2% | 0.00% | 0.0% |
| Q4 2013 | $1,973,000 | +32.9% | 139,500 | -1.6% | 0.00% | 0.0% |
| Q3 2013 | $1,485,000 | +52.0% | 141,740 | +13.3% | 0.00% | +50.0% |
| Q2 2013 | $977,000 | – | 125,140 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,000,000 | $66,540,000 | 6.69% |
| FIC CAPITAL INC | 787,529 | $8,734,000 | 3.47% |
| RA Capital Management | 1,220,209 | $13,532,000 | 1.36% |
| PRINCETON CAPITAL MANAGEMENT INC | 114,120 | $1,266,000 | 0.67% |
| Perceptive Advisors | 800,000 | $8,872,000 | 0.53% |
| Cormorant Asset Management, LP | 361,000 | $4,003,000 | 0.53% |
| Highlander Capital Management, LLC | 43,500 | $482,000 | 0.43% |
| APEX CAPITAL, LLC | 439,900 | $4,878,000 | 0.42% |
| WASATCH ADVISORS LP | 3,091,386 | $34,283,000 | 0.37% |
| Baker Brothers Advisors | 3,230,932 | $35,831,000 | 0.31% |